Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Anxiety Disorders, Parkinson Disease

In brief

This study will evaluate the effectiveness of the rotigotine transdermal patch in reducing anxiety in people with Parkinson's disease.

Key facts

Study ID

NCT02365870

Run by

Johns Hopkins University

People needed

4

Starts

2016-08-01

Expected to finish

2019-07-01

Last updated by the study team

2020-03-31

Who can join

Age: 21 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 Anxiety Disorder
• Stable medical history and general health
• On stable anti-parkinsonian therapy for 2 weeks before enrollment

You may not qualify if…

• Unstable medical disease of comorbid psychiatric disease
• Dementia
• Subjects with less than one year duration of Parkinson's
• Current treatment with a dopamine agonist

Where it is running

• Johns Hopkins University School of Medicine — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.